Lamb Weston
LW
48.09
+0.18
+0.38%
Lamb Weston
US · LW
#1927 by market cap
Listed 2016
48.09
+0.18
+0.38%
Live - 5344 symbols - heartbeat 378s ago
· 2026-10-08 08:28
Pre-market
48.50
+0.85%
After-hours
48.09
0.00%
Overnight
47.76
-0.69%
- Market cap
- 6.63B
- P/E (TTM)i
- 26.28
- P/Bi
- 3.67
- EPSi
- 2.08
- Div yieldi
- 3.14%
- 52W posi
- 39%
Reader sentiment
Are you bullish or bearish on LW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.58, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.50% YoY
Margins
- Gross margin
- 20.56%
- Operating margin
- 10.51%
- Net margin
- 4.39%
Key ratios & quality
- Enterprise valuei
- 10.50B
- Altman Z-Scorei
- 2.58
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.76B | 3.79B | 3.67B | 4.10B | 5.35B | 6.47B | 6.45B | 6.61B |
| Gross profit | 1.00B | 895.20M | 832.00M | 832.00M | 1.43B | 1.77B | 1.40B | 1.36B |
| Selling & admin expenses | 335.10M | 338.30M | 357.20M | 387.60M | 550.00M | 701.40M | 633.50M | 664.60M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 668.40M | 556.90M | 474.80M | 444.40M | 882.10M | 1.07B | 765.10M | 695.10M |
| Pretax profit | 561.30M | 448.90M | 356.50M | 283.40M | 772.90M | 929.50M | 485.10M | 410.60M |
| Tax | 133.60M | 112.30M | 90.50M | 71.80M | 224.60M | 230.00M | 143.10M | 128.10M |
| Net profit | 487.20M | 365.90M | 317.80M | 200.90M | 1.01B | 725.50M | 357.20M | 290.00M |
| Basic EPS | 3 | 3 | 2 | 1 | 7 | 5 | 3 | 2 |
| Diluted EPS | 3.18 | 2.49 | 2.16 | 1.38 | 6.95 | 4.98 | 2.50 | 2.08 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 1.68B | 1.66B | 1.62B | 1.56B | 1.77B | 1.67B |
| Gross profit | 342.30M | 342.40M | 324.30M | 331.60M | 361.40M | 266.50M |
| Selling & admin expenses | 175.00M | 153.60M | 167.80M | 144.90M | 217.70M | 170.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 201.60M | 188.80M | 153.30M | 174.80M | 178.20M | 96.30M |
| Pretax profit | 141.60M | 112.80M | 94.90M | 81.60M | 121.30M | 39.80M |
| Tax | 21.40M | 47.90M | 36.00M | 30.30M | 13.90M | 16.90M |
| Net profit | 119.90M | 64.30M | 62.10M | 54.00M | 109.60M | 29.10M |
| Basic EPS | 1 | 0 | 0 | 0 | 1 | 0 |
| Diluted EPS | 0.85 | 0.46 | 0.44 | 0.39 | 0.79 | 0.21 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 961.50M | 2.30B | 1.78B | 1.66B | 2.13B | 2.09B | 2.03B | 2.01B |
| Cash & ST investments | 12.20M | 1.36B | 783.50M | 525.00M | 304.80M | 71.40M | 70.70M | 68.20M |
| Inventory | 498.30M | 486.70M | 513.50M | 574.40M | 932.00M | 1.14B | 1.04B | 968.50M |
| Total assets | 3.05B | 4.66B | 4.21B | 4.14B | 6.52B | 7.37B | 7.39B | 7.38B |
| Total current liabilities | 552.80M | 1.02B | 618.20M | 699.10M | 1.36B | 1.62B | 1.48B | 1.42B |
| Short-term debt | 46.40M | 575.90M | 61.10M | 54.60M | 242.30M | 412.00M | 472.50M | 347.70M |
| Long-term debt | 2.28B | 2.99B | 2.71B | 2.70B | 3.25B | 3.44B | 3.68B | 3.60B |
| Total liabilities | 3,052,700,000.00 | 4,422,300,000.00 | 3,728,800,000.00 | 3,779,300,000.00 | 5,108,500,000.00 | 5,579,200,000.00 | 5,654,900,000.00 | 5,555,200,000.00 |
| Total equity | -4.60M | 240.00M | 480.60M | 360.50M | 1.41B | 1.79B | 1.74B | 1.82B |
| Retained earnings | 803.60M | 1.06B | 1.24B | 1.31B | 2.16B | 2.70B | 2.85B | 2.93B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 2.03B | 1.87B | 2.01B | 2.06B | 2.01B | 2.05B |
| Cash & ST investments | 70.70M | 98.60M | 82.70M | 57.50M | 68.20M | 166.30M |
| Inventory | 1.04B | 906.80M | 1.12B | 1.09B | 968.50M | 965.30M |
| Total assets | 7.39B | 7.24B | 7.33B | 7.39B | 7.38B | 7.32B |
| Total current liabilities | 1.48B | 1.26B | 1.40B | 1.41B | 1.42B | 1.41B |
| Short-term debt | 472.50M | 320.70M | 295.80M | 377.90M | 347.70M | 378.20M |
| Long-term debt | 3.68B | 3.67B | 3.65B | 3.64B | 3.60B | 3.58B |
| Total liabilities | 5,654,900,000.00 | 5,446,900,000.00 | 5,576,600,000.00 | 5,566,400,000.00 | 5,555,200,000.00 | 5,516,600,000.00 |
| Total equity | 1.74B | 1.79B | 1.75B | 1.83B | 1.82B | 1.81B |
| Retained earnings | 2.85B | 2.86B | 2.87B | 2.87B | 2.93B | 2.90B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 680.90M | 574.00M | 552.70M | 418.60M | 761.70M | 798.20M | 868.30M | 942.90M |
| Depreciation & amortization | 162.40M | 182.30M | 187.80M | 192.10M | 222.80M | 306.80M | 374.80M | 396.70M |
| Free cash flow | 346.70M | 406.30M | 405.50M | 128.50M | 107.70M | -131.30M | 230.10M | 540.20M |
| Dividends paid | -113.30M | -121.30M | -135.30M | -138.40M | -146.10M | -174.00M | -206.90M | -207.50M |
| Stock buybacks / issuance | -36.40M | -28.90M | -36.10M | -158.40M | -51.60M | -225.30M | -294.40M | -122.80M |
| Ending cash balance | 12.20M | 1.36B | 783.50M | 525.00M | 304.80M | 71.40M | 70.70M | 68.20M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 383.00M | 352.00M | 178.40M | 65.20M | 347.30M | 234.80M |
| Depreciation & amortization | 95.00M | 95.30M | 96.20M | 100.30M | 104.90M | 100.90M |
| Free cash flow | 295.20M | 274.40M | 101.00M | -36.30M | 201.10M | 146.10M |
| Dividends paid | -52.20M | -51.70M | -51.60M | -51.40M | -52.80M | -52.20M |
| Stock buybacks / issuance | -100.60M | -18.70M | -40.40M | -100.00K | -63.60M | -7.70M |
| Ending cash balance | 70.70M | 98.60M | 82.70M | 57.50M | 68.20M | 166.30M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | 310.88 | 88.20 | 47.77 | 113.88 | 45.36 | 20.26 | 16.28 |
| ROA %i | 16.13 | 9.49 | 7.16 | 4.81 | 18.93 | 10.45 | 4.84 | 3.93 |
| ROIC %i | -- | 14.63 | 11.62 | 10.05 | 27.41 | 15.72 | 8.42 | 7.12 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | 121.22 | 63.10 | 48.71 |
| EBIT margin %i | 17.79 | 14.68 | 12.93 | 10.84 | 16.49 | 16.47 | 10.31 | 8.94 |
| FCF / sales %i | 9.23 | 10.71 | 11.06 | 3.12 | 2.01 | -- | 3.57 | 8.17 |
| Current ratioi | 1.74 | 2.25 | 2.88 | 2.37 | 1.56 | 1.29 | 1.38 | 1.42 |
| Quick ratioi | 0.64 | 1.66 | 1.86 | 1.39 | 0.76 | 0.50 | 0.58 | 0.60 |
| Debt / assetsi | 76.33 | 76.54 | 65.72 | 66.44 | 53.54 | 52.30 | 56.21 | 53.43 |
| LT debt / equityi | -- | 1,246.92 | 562.92 | 747.79 | 230.17 | 192.45 | 211.94 | 197.01 |
| Interest coveragei | 6.24 | 5.16 | 4.01 | 2.76 | 8.08 | 7.84 | 3.70 | 3.27 |
| Revenue CAGR (3Y) %i | 7.86 | 6.18 | 2.35 | 2.95 | 12.16 | 20.78 | 16.32 | 7.31 |
| Net income CAGR (3Y) %i | 18.82 | 3.83 | -8.64 | -25.13 | 40.23 | 31.67 | 21.15 | -34.00 |
| FCF CAGR (3Y) %i | 14.66 | 36.57 | 32.48 | -28.17 | -35.76 | -- | 21.43 | 71.18 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 20.26 | 16.22 | 23.16 | 17.35 | 16.28 | -- |
| ROA %i | 4.84 | 3.99 | 5.31 | 4.05 | 3.93 | -- |
| ROIC %i | 8.42 | 7.10 | 9.07 | 7.18 | 7.12 | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.31 | 9.44 | 11.28 | 9.33 | 8.94 | -- |
| FCF / sales %i | 3.57 | 7.75 | 10.05 | 9.73 | 8.17 | -- |
| Current ratioi | 1.38 | 1.49 | 1.43 | 1.46 | 1.42 | -- |
| Quick ratioi | 0.58 | 0.69 | 0.59 | 0.57 | 0.60 | -- |
| Debt / assetsi | 56.21 | 55.16 | 53.81 | 54.38 | 53.43 | -- |
| LT debt / equityi | 211.94 | 205.10 | 207.99 | 199.38 | 197.01 | -- |
| Interest coveragei | 3.70 | 3.41 | 4.07 | 3.43 | 3.27 | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Region
United States64.87%
Other35.13%
Quote time 2026-10-08 08:28:33 · For reference only, not investment advice and not tailored to your situation.